Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Walker MM, Roberts JA, Li Y, Naicker S, et al. Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant Escherichia coli using a hollow fiber infection model: a proof-of-concept study. Antimicrob Agents Chemother 2026;70:e0137725.
PMID: 42089826


Privacy Policy